Skip to main navigation

Investor Relations

Who We Are + -
What We Do + -
Our Progress + -
- Pipeline
Join the Team + -
- Job Opportunities
- Culture
Investors & Media + -

Let’s Talk

+

Investors

News & Events

News & Events

Press Releases
Events & Presentations

Year

10.15 2020

Sanofi and Translate Bio mRNA COVID-19 Vaccine Candidate Induced High Antibody Levels in Preclinical Studies

10.07 2020

Translate Bio Highlights mRNA Platform Potential for the Treatment of Cystic Fibrosis (CF) at the 34th Annual North American Cystic Fibrosis Conference

09.29 2020

Translate Bio to Participate in Upcoming Investor Conferences

09.08 2020

Translate Bio Resumes Enrollment and Dosing in Phase 1/2 Clinical Trial of MRT5005 in Cystic Fibrosis

09.03 2020

Translate Bio to Participate in Upcoming Investor Conferences

08.06 2020

Translate Bio Announces Second Quarter 2020 Financial Results and Reviews Recent Progress

07.20 2020

Translate Bio Announces Closing of Expanded Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for All Infectious Diseases

06.25 2020

Translate Bio Announces Pricing of Public Offering of Common Stock

06.24 2020

Translate Bio Announces Proposed Public Offering of Common Stock

06.23 2020

Sanofi and Translate Bio Expand Collaboration to Develop mRNA Vaccines Across All Infectious Disease Areas

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 18

Presentations

Corporate Presentation 1.6 MB

2020 NACFC Oral Presentation 2.4 MB

2020 NACFC Poster Presentation 484.2 KB

2019 NACFC Oral Presentation 624.5 KB

2019 NACFC Poster Presentation 1.8 MB

Upcoming Events

11.09 - 11.10 2020 at 11:59 PM EST

8th International mRNA Health Conference

Past Events

05.10 2018

TIDES 2018

04.25 2018

World Orphan Drug Congress USA

11.17 2017

The Cystic Fibrosis Foundation’s Uncork the Cure

11.02 2017

North American Cystic Fibrosis Conference

11.01 2017

5th International mRNA Health Conference

09.28 2017

Discovery on Target – Emerging Oligonucleotide Therapeutics

09.27 2017

2nd International Ataxia Research Conference

09.24 2017

The 13th Annual Meeting of the Oligonucleotide Therapeutics Society

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Current page 5

Investor Tools

Contact Us

Email Alerts

RSS Feeds

Print Page

Mobile Footer Menu

Who We Are
What We Do
Our Progress
Join the Team
Investors

Who We Are

About Us
Leadership
Partnering
Contact

What We Do

mRNA Therapeutics
Scientific Platform
Areas of Focus
Publications

Our Progress

Pipeline

Join the Team

Culture
Job Opportunities

Investors

Overview
News & Events
Financials and Filings
Corporate Governance
Stock Information
Investor Resources

Terms of Use
Privacy Policy

© 2018 Translate Bio All rights reserved.